132 related articles for article (PubMed ID: 38430625)
1. Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.
Rakotoarisoa L; Weiss L; Lefebvre F; Porzio M; Renaud-Picard B; Ravoninjatovo B; Abely M; Danner-Boucher I; Dubois S; Troussier F; Prevotat A; Rault G; Kessler R; Kessler L
J Diabetes Complications; 2024 Apr; 38(4):108703. PubMed ID: 38430625
[TBL] [Abstract][Full Text] [Related]
2. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
3. The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis.
Chan CL; Pyle L; Vigers T; Zeitler PS; Nadeau KJ
J Clin Endocrinol Metab; 2022 Jan; 107(2):e548-e560. PubMed ID: 34537845
[TBL] [Abstract][Full Text] [Related]
4. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.
Leclercq A; Gauthier B; Rosner V; Weiss L; Moreau F; Constantinescu AA; Kessler R; Kessler L
J Cyst Fibros; 2014 Jul; 13(4):478-84. PubMed ID: 24359972
[TBL] [Abstract][Full Text] [Related]
5. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
[TBL] [Abstract][Full Text] [Related]
6. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
[TBL] [Abstract][Full Text] [Related]
7. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
Taylor-Cousar JL; Janssen JS; Wilson A; Clair CG; Pickard KM; Jones MC; Brayshaw SJ; Chacon CS; Barboa CM; Sontag MK; Accurso FJ; Nichols DP; Saavedra MT; Nick JA
J Diabetes Res; 2016; 2016():1527932. PubMed ID: 27999822
[No Abstract] [Full Text] [Related]
8. Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis.
Brodsky J; Dougherty S; Makani R; Rubenstein RC; Kelly A
Diabetes Care; 2011 Feb; 34(2):292-5. PubMed ID: 21228248
[TBL] [Abstract][Full Text] [Related]
9. Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?
Zorron M; Marson FAL; Morcillo AM; Gonçalves AC; El Beck MS; Ribeiro JD; Ribeiro AF
J Bras Pneumol; 2022; 48(2):e20210307. PubMed ID: 35475864
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Continuous Glucose Monitoring in Cystic Fibrosis Patients With or Without Pancreatic Exocrine Insufficiency.
Rakotoarisoa L; Weiss L; Lefebvre F; Porzio M; Ravoninjatovo B; Abely M; Boucher ID; Dubois S; Troussier F; Gilles R; Prevotat A; Kessler L
Horm Metab Res; 2022 Jun; 54(6):407-412. PubMed ID: 35272389
[TBL] [Abstract][Full Text] [Related]
11. Glycemic indices at night measured by CGM are predictive for a lower pulmonary function in adults but not in children with cystic fibrosis.
Declercq D; Helleputte S; Marchand S; Van Aken S; Van Braeckel E; Van Daele S; T'Sjoen G; Van Biervliet S; Lapauw B
J Cyst Fibros; 2023 Jan; 22(1):59-65. PubMed ID: 36068119
[TBL] [Abstract][Full Text] [Related]
12. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.
Prentice BJ; Chelliah A; Ooi CY; Hameed S; Verge CF; Plush L; Widger J
J Cyst Fibros; 2020 Mar; 19(2):305-309. PubMed ID: 31126898
[TBL] [Abstract][Full Text] [Related]
13. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
14. Abnormal glucose tolerance and lung function in children with cystic fibrosis. Comparing oral glucose tolerance test and continuous glucose monitoring.
Elidottir H; Diemer S; Eklund E; Hansen CR
J Cyst Fibros; 2021 Sep; 20(5):779-784. PubMed ID: 33478894
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemia in children and young adults with cystic fibrosis during oral glucose tolerance testing vs. continuous glucose monitoring.
Finn E; Severn C; Pyle L; Garrish J; Vigers T; Behn CGD; Zeitler PS; Sagel SD; Nadeau KJ; Chan CL
Pediatr Pulmonol; 2023 Sep; 58(9):2495-2504. PubMed ID: 37350354
[TBL] [Abstract][Full Text] [Related]
16. The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis.
Kirigin Biloš LS; Altabas V; Vukić Dugac A; Baretić M
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541202
[TBL] [Abstract][Full Text] [Related]
17. The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis-related diabetes.
Gileles-Hillel A; Soesman LH; Miari S; Breuer O; Tsabari R; Elyashar-Earon H; Armoni S; Sprikkelman AB; Reiter J; Zangen D; Lavi E; Kerem E; Cohen-Cymberknoh M
Pediatr Pulmonol; 2022 Nov; 57(11):2774-2780. PubMed ID: 35999051
[TBL] [Abstract][Full Text] [Related]
18. Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain.
Hameed S; Morton JR; Jaffé A; Field PI; Belessis Y; Yoong T; Katz T; Verge CF
Diabetes Care; 2010 Feb; 33(2):221-6. PubMed ID: 19910502
[TBL] [Abstract][Full Text] [Related]
19. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
[TBL] [Abstract][Full Text] [Related]
20. Continuous glucose monitoring to evaluate glycaemic abnormalities in cystic fibrosis.
Zorrón Mei Hsia Pu M; Gonçalves AC; Minnicucci WJ; Morcillo AM; Ribeiro JD; Ribeiro AF
Arch Dis Child; 2018 Jun; 103(6):592-596. PubMed ID: 29378680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]